Year: 2022

Health Care as a Human Right? Why Not?

November 29, 2022 Sponsored Content Views

Introducing Avita’s Dr. Joel Rosenstock & Our Commitment to Health Equity

340B Hospitals Use Biosimilars Less Than Others, PhRMA-Commissioned Study Finds

November 29, 2022 Tom Mirga, Editor at Large Views

graphic image of biosimilar pills depicted equal on a scale

340B hospitals use biosimilar drugs less than other hospitals, a PhRMA-funded study found.

340B hospitals use biosimilar drugs less than other hospitals, which may expose patients to higher out-of-pocket costs, a drug industry funded study concludes.

Pharmaceutical Research and Manufacturers of America released the study last week. Healthcare consulting firm Milliman did the research for

…

340B Prime Vendor Sued for Allegedly Not Negotiating Sub-Ceiling Pricing on HIV/AIDS Drugs

November 22, 2022 Tom Mirga, Editor at Large Views

AIDS Healthcare Foundation says in a lawsuit that Apexus, the 340B prime vendor, fails and refuses to negotiate sub-ceiling 340B discounts on HIV/AIDS medicines.

AIDS Healthcare Foundation sued Apexus, the federally contracted 340B prime vendor, on Friday for allegedly failing and refusing to negotiate sub-ceiling 340B discounts on HIV/AIDS prescription drugs pursuant to its agreement with the government.

An Apexus spokesperson yesterday said it

…

Arkansas Health System Asks State to Enforce its 340B Contract Pharmacy Law Against Novo Nordisk

November 22, 2022 Laura Gilcrest, Contributor Views

Arkansas Insurance Department office sign

An Arkansas health system has asked state insurance officials to enforce the state's 340B contract pharmacy anti-discrimination law against Novo Nordisk.

An Arkansas health system is urging state officials to enforce the state’s novel 340B contract pharmacy anti-discrimination law against drug maker Novo Nordisk to end the company’s restrictions on 340B-priced drugs dispensed at multiple contract pharmacies. The lawsuit marks the

…

Important Operational Insights for Covered Entities Choosing to Access 340B ESP

November 22, 2022 Sponsored Content Views

Key Considerations for Streamlining 340B ESP Use

CMS Defends Delayed Fix for Illegal Medicare Drug Payment Cuts for 340B Hospitals

November 22, 2022 Laura Gilcrest, Contributor Views

pill bottle and Medicare health insurance card

CMS defends its decision to wait until next year to decide how to remedy illegal past cuts in 340B hospitals Part B drug reimbursement.

Federal health officials last week defended their plan to wait until next year to say how they will reimburse 340B hospitals for illegal Medicare Part B drug payment cuts in place for the past five years after hospital groups told

…

HRSA Sanctions Manufacturer for Not Issuing Refund for 340B Overcharges

November 22, 2022 Tom Mirga, Editor at Large Views

HRSA has ordered Pennsylvania-based generic drug manufacturer KVK Tech to repay 340B covered entities for program violations found during an audit.

The U.S. Health Resources and Services Administration has ordered Pennsylvania-based generic drug manufacturer KVK Tech to repay 340B covered entities for program violations found during an audit.

HRSA posted its audit findings Nov. 15. “KVK-Tech failed to refund covered entities for

…

White House Gives HRSA Green Light to Publish Proposed New 340B Dispute Resolution Regulations

November 17, 2022 Tom Mirga, Editor at Large Views

Screenshot of reginfo.gov 340B program ADR record

The White House yesterday authorized HRSA to publish a proposed rule to replace the 340B administrative dispute resolution final rule HRSA promulgated in late December 2020.

The White House yesterday unexpectedly gave the U.S. Health Resources and Services Administration permission to publish a proposed replacement for HRSA’s December 2020 340B administrative dispute resolution final rule.

The Office of Management and Budget announced on its website Nov.

…

A Closer Look at Tuesday’s Arguments in Federal Appeals Court Over the Legality of the 340B Contract Pharmacy Program

November 17, 2022 Tom Mirga, Editor at Large Views

Today 340B Report takes a closer look at Tuesday's oral arguments in federal circuit court in Philadelphia in three 340B contract pharmacy lawsuits.

On Tuesday we reported about oral arguments before a federal appeals court in Philadelphia in AstraZeneca, Novo Nordisk, and Sanofi’s lawsuits challenging federal agency findings that the companies’ conditions on 340B covered entities’ use of contract pharmacies violate the 340B statute.

…